HOLX Hologic Inc

Price (delayed)

$65.63

Market cap

$16.82B

P/E Ratio

8.93

Dividend/share

N/A

EPS

$7.35

Enterprise value

$18.77B

Sector: Healthcare
Industry: Medical Instruments & Supplies

Hologic, Inc. is a medical technology company primarily focused on women’s health; it sells medical devices for diagnostics, surgery, and medical imaging. In late November 2013, activist investor Carl Icahn ...

Highlights

The gross profit has soared by 140% YoY and by 23% from the previous quarter
Hologic's quick ratio has surged by 109% YoY

Key stats

What are the main financial stats of HOLX
Market
Shares outstanding
256.23M
Market cap
$16.82B
Enterprise value
$18.77B
Valuations
Price to earnings (P/E)
8.93
Price to book (P/B)
4.46
Price to sales (P/S)
3.19
EV/EBIT
7.5
EV/EBITDA
6.52
EV/Sales
3.53
Earnings
Revenue
$5.32B
EBIT
$2.5B
EBITDA
$2.88B
Free cash flow
$1.69B
Per share
EPS
$7.35
Free cash flow per share
$6.53
Book value per share
$14.73
Revenue per share
$20.57
TBVPS
$14.47
Balance sheet
Total assets
$8.04B
Total liabilities
$4.25B
Debt
$2.77B
Equity
$3.79B
Working capital
$1.63B
Liquidity
Debt to equity
0.73
Current ratio
2.57
Quick ratio
1.96
Net debt/EBITDA
0.68
Margins
EBITDA margin
54.2%
Gross margin
68.9%
Net margin
35.9%
Operating margin
46.9%
Efficiency
Return on assets
25.8%
Return on equity
63.5%
Return on invested capital
56.6%
Return on capital employed
35.7%
Return on sales
47.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HOLX stock price

How has the Hologic stock price performed over time
Intraday
0.72%
1 week
0.12%
1 month
-9.97%
1 year
23.97%
YTD
-9.89%
QTD
-11.76%

Financial performance

How have Hologic's revenue and profit performed over time
Revenue
$5.32B
Gross profit
$3.66B
Operating income
$2.5B
Net income
$1.91B
Gross margin
68.9%
Net margin
35.9%
The company's net margin has surged by 164% YoY and by 18% QoQ
The gross profit has soared by 140% YoY and by 23% from the previous quarter
The revenue has soared by 60% YoY and by 17% from the previous quarter
Hologic's gross margin has surged by 50% YoY and by 5% QoQ

Growth

What is Hologic's growth rate over time

Valuation

What is Hologic stock price valuation
P/E
8.93
P/B
4.46
P/S
3.19
EV/EBIT
7.5
EV/EBITDA
6.52
EV/Sales
3.53
The stock's price to earnings (P/E) is 47% less than its last 4 quarters average of 16.9
The EPS is up by 38% since the previous quarter
HOLX's equity has surged by 82% year-on-year and by 16% since the previous quarter
HOLX's price to book (P/B) is 23% lower than its last 4 quarters average of 5.8 and 13% lower than its 5-year quarterly average of 5.1
The revenue has soared by 60% YoY and by 17% from the previous quarter
HOLX's price to sales (P/S) is 22% lower than its last 4 quarters average of 4.1 and 16% lower than its 5-year quarterly average of 3.8

Efficiency

How efficient is Hologic business performance
HOLX's return on invested capital is up by 32% since the previous quarter
Hologic's return on assets has increased by 32% QoQ
The ROE has grown by 18% from the previous quarter
The return on sales is up by 15% since the previous quarter

Dividends

What is HOLX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HOLX.

Financial health

How did Hologic financials performed over time
The total assets is 89% higher than the total liabilities
Hologic's quick ratio has surged by 109% YoY
Hologic's current ratio has soared by 96% YoY and by 4.5% from the previous quarter
The company's debt is 27% lower than its equity
HOLX's equity has surged by 82% year-on-year and by 16% since the previous quarter
Hologic's debt to equity has plunged by 57% YoY and by 14% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.